SEC Form 4 · accession 0001235802-17-000160

ENTELLUS MEDICAL INC · ENTL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP Marketing

Period of report

Oct 16, 2017

Accepted (ET)

Oct 18, 2017 · 7:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001374128

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock, $0.001 par value^F1	Oct 16, 2017	M	10,000	$1.24	A	17,500	D
Common Stock, $0.001 par value^F3,F1	Oct 16, 2017	S	10,000	$18.2903	D	7,500	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F4	$1.24	Oct 16, 2017	M	10,000	D	—	Apr 8, 2023	Common Stock	10,000	61,400	D

F1Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
F2These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.64, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
F4This option vested as to twenty-five percent (25%) of the shares underlying the option on April 8, 2014, with the remaining shares vesting in 36 substantially equal monthly installments on each monthly anniversary of the grant date thereafter, subject to continued employment or service with the Issuer through each applicable vesting date.